CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.

CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.

Chemokines are a family of low molecular weight proteins with an essential role in leukocyte trafficking during both homeostasis and inflammation. The CC class of chemokines consists of at least 28 members (CCL1-28) that signal through 10 known chemokine receptors (CCR1-10). CC chemokine receptors a...

Full description

Bibliographic Details
Main Authors:	White, G, Iqbal, A, Greaves, D
Format:	Journal article
Language:	English
Published:	American Society for Pharmacology and Experimental Therapy 2013

Similar Items

Expression of a membrane associated CC-chemokine inhibitor protein reduces in vitro macrophage chemotaxis to CC chemokines
by: McNeill, E, et al.
Published: (2010)

Hydrodynamic gene delivery of CC chemokine binding Fc fusion proteins to target acute vascular inflammation in vivo.
by: McNeill, E, et al.
Published: (2015)

Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2006)

Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.
by: White, G, et al.
Published: (2011)

Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
by: Jan Korbecki, et al.
Published: (2020-08-01)

A membrane-bound vaccinia viral protein 'mem35k' blocks CC-chemokine induced cell migration and CC-chemokine activity in vitro
by: Bursill, C, et al.
Published: (2005)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
by: Liu F, et al.
Published: (2021-02-01)

Adenoviral mediated delivery of a vaccinia viral protein (35K) blocks CC-chemokine activity in vitro and in vivo and may therefore be a useful therapeutic strategy to reduce the initiation and progression of CC-chemokine induced atherosclerosis
by: Bursill, C, et al.
Published: (2003)

CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis
by: APMP Marino, et al.
Published: (2005-03-01)

Chemokines, chemokine receptors and atherosclerosis
by: John, A, et al.
Published: (2005)

Epigenetic regulation of CC-chemokine ligand 2 in nonresolving inflammation
by: Kiguchi Norikazu, et al.
Published: (2014-08-01)

Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
by: Bursill, C, et al.
Published: (2003)

Contrasting in vitro vs. in vivo effects of a cell membrane-specific CC-chemokine binding protein on macrophage chemotaxis.
by: McNeill, E, et al.
Published: (2014)

Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
by: Dawei Sun, et al.
Published: (2023-12-01)

CC chemokines and receptors in osteoarthritis: new insights and potential targets
by: Yuchen Zhang, et al.
Published: (2023-07-01)

Generation and site-directed mutagenesis of a 35K-Fc fusion protein with increased potency of CC chemokine blockade
by: White, G, et al.
Published: (2010)

Novel aspects of chemokine receptor signalling in cardiovascular inflammation
by: Patel, J, et al.
Published: (2018)

CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
by: Shanshan Liu, et al.
Published: (2023-02-01)

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
by: Assunta Venuti, et al.
Published: (2017-10-01)

The roles of CC chemokines in response to radiation
by: Lei Wang, et al.
Published: (2022-04-01)

CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration
by: Xinghe Liao, et al.
Published: (2024-01-01)

CC chemokine receptor 7 promotes macrophage recruitment and induces M2-polarization through CC chemokine ligand 19&21 in oral squamous cell carcinoma
by: Wan-Hang Zhou, et al.
Published: (2022-07-01)

Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition.
by: Bursill, C, et al.
Published: (2009)

Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment
by: Xinyuan Liu, et al.
Published: (2023-04-01)

Adenoviral delivery of CC-chemokine inhibitor '35K' reduces macrophage recruitment and atherosclerosis in ApoE knockout mice
by: Bursill, C, et al.
Published: (2004)

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells.
by: Greaves, D, et al.
Published: (1997)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
by: Wei, Z, et al.
Published: (2005)

CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
by: Joanna Bogacka, et al.
Published: (2022-12-01)

Fractalkine: one chemokine, many functions.
by: White, G, et al.
Published: (2009)

FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
by: N. V. Kipich, et al.
Published: (2014-07-01)

CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6
by: Andy Chevigné, et al.
Published: (2021-03-01)

Role of CC-chemokine ligand 2 in gynecological cancer
by: Jia-Jia Zhang, et al.
Published: (2022-11-01)

Adenoviral delivery of a Cc-chemokine inhibitor, "35k," reduces macrophage recruitment and atherosclerosis in Apoe knockout mice
by: Bursill, C, et al.
Published: (2004)

Adenoviral-mediated delivery of a CC-chemokine inhibitor ('35K') attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
by: Bursill, C, et al.
Published: (2004)

Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators.
by: White, G, et al.
Published: (2012)

Adenoviral mediated delivery of a CC chemokine (CK) inhibitor ("35K") attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
by: Bursill, C, et al.
Published: (2004)

Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
by: Christian Berg, et al.
Published: (2023-02-01)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
by: Leah M. Salinsky, et al.
Published: (2023-10-01)

Abrogation of CC Chemokine Receptor 9 Ameliorates Ventricular Electrical Remodeling in Mice After Myocardial Infarction
by: Yan Huang, et al.
Published: (2021-10-01)

Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
by: Bursill, C, et al.
Published: (2004)